These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 15808577
1. Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamune. Brook NR, Waller JR, Bicknell GR, Nicholson ML. Transplant Proc; 2005; 37(1):148-9. PubMed ID: 15808577 [Abstract] [Full Text] [Related]
3. Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage. Brook NR, Waller JR, Bicknell GR, Nicholson ML. Transplant Proc; 2005 Mar; 37(2):837-8. PubMed ID: 15848549 [Abstract] [Full Text] [Related]
4. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats. Lloberas N, Torras J, Alperovich G, Cruzado JM, Giménez-Bonafé P, Herrero-Fresneda I, Franquesa Ml, Rama I, Grinyó JM. Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305 [Abstract] [Full Text] [Related]
6. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. Han DH, Piao SG, Song JH, Ghee JY, Hwang HS, Choi BS, Kim J, Yang CW. Transplantation; 2010 Jul 27; 90(2):135-41. PubMed ID: 20562737 [Abstract] [Full Text] [Related]
7. The experimental agent pirfenidone reduces pro-fibrotic gene expression in a model of tacrolimus-induced nephrotoxicity. Brook NR, Waller JR, Bicknell GR, Nicholson ML. J Surg Res; 2005 May 15; 125(2):137-43. PubMed ID: 15854665 [Abstract] [Full Text] [Related]
9. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, Dart A, Du XJ. J Hypertens; 2006 Aug 15; 24(8):1663-70. PubMed ID: 16877971 [Abstract] [Full Text] [Related]
12. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR. Nephrol Dial Transplant; 2006 Sep 15; 21(9):2406-16. PubMed ID: 16728425 [Abstract] [Full Text] [Related]
16. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy. Ma X, Lu YP, Yang L, Song J, Luo GH, Shi YJ, Li YP. Transplant Proc; 2008 Oct 15; 40(8):2804-7. PubMed ID: 18929866 [Abstract] [Full Text] [Related]
17. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. Bonegio RG, Fuhro R, Wang Z, Valeri CR, Andry C, Salant DJ, Lieberthal W. J Am Soc Nephrol; 2005 Jul 15; 16(7):2063-72. PubMed ID: 15917339 [Abstract] [Full Text] [Related]
18. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L. Nephrol Dial Transplant; 2005 Nov 15; 20(11):2517-23. PubMed ID: 15985508 [Abstract] [Full Text] [Related]
19. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease. Berthier CC, Wahl PR, Le Hir M, Marti HP, Wagner U, Rehrauer H, Wüthrich RP, Serra AL. Nephrol Dial Transplant; 2008 Mar 15; 23(3):880-9. PubMed ID: 18042615 [Abstract] [Full Text] [Related]